Transcranial magnetic stimulation for the treatment of depression: Current knowledge and future directions

  • M. S. George
  • , J. H. Chae
  • , Z. Nahas
  • , X. Li
  • , A. Najib
  • , M. Lomarev
  • , S. Denslow
  • , N. Oliver
  • , D. Bohning

Research output: Contribution to journalArticlepeer-review

Abstract

In summary, rTMS is a safe, relatively noninvasive new technology that allows for the direct stimulation of cortical brain regions. It appears that rTMS at different frequencies has divergent effects on brain activity and can modulate mood in health and disease. The clinical role of rTMS in treating depression remains unclear. Many different groups are studying TMS effects on mood and the field is advancing rapidly. TMS is an exciting area with promise as a research and clinical tool.

Original languageEnglish
Pages (from-to)31-54
Number of pages24
JournalPsychiatric Clinics of North America: Annual of Drug Therapy
StatePublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Transcranial magnetic stimulation for the treatment of depression: Current knowledge and future directions'. Together they form a unique fingerprint.

Cite this